申请人:Celgene Corporation
公开号:US05968945A1
公开(公告)日:1999-10-19
Novel amides and imides are inhibitors of tumor necrosis factor.alpha. and phosphodiesterase and can be used to combat cachexia, endotoxic shock, retrovirus replication, asthma, and inflammatory conditions. Typical embodiments include 3-(1,3-dioxobenzo[f]isoindol-2-yl)-3-(3-cyclopentyloxy-4-methoxyphenyl)pro pionamide and 3-(1,3-dioxo-4-azaisoindol-2-yl)-3-(3,4-dimethoxyphenyl)-propionarnide.
新型酰胺和亚酰胺是肿瘤坏死因子α和磷酸二酯酶的抑制剂,可用于对抗消瘦症、内毒素休克、逆转录病毒复制、哮喘和炎症等疾病。典型的实施例包括3-(1,3-二氧杂苯并[ f ]异吲哚-2-基)-3-(3-环戊氧基-4-甲氧基苯基)丙酰胺和3-(1,3-二氧杂-4-氮杂异吲哚-2-基)-3-(3,4-二甲氧基苯基)-丙酰胺。